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This study evaluated tracheal regeneration studies using scientometric and co-occurrence analysis to identify the
most important topics and assess their trends over time. To provide the adequate search options, PubMed, Scopus,
and Web of Science (WOS) were used to cover various categories such as keywords, countries, organizations, and
authors. Search results were obtained by employing Bibexcel. Co-occurrence analysis was applied to evaluate the
publications. Finally, scientific maps, author’s network, and country contributions were depicted using VOS-
viewer and NetDraw. Furthermore, the first 25 countries and 130 of the most productive authors were determined.
Regarding the trend analysis, 10 co-occurrence terms out of highly frequent words were examined at 5-year
intervals. Our findings indicated that the field of trachea regeneration has tested different approaches over the time.
In total, 65 countries have contributed to scientific progress both in experimental and clinical fields. Special
keywords such as tissue engineering and different types of stem cells have been increasingly used since 1995.
Studies have addressed topics such as angiogenesis, decellularization methods, extracellular matrix, and me-
chanical properties since 2011. These findings will offer evidence-based information about the current status and
trends of tracheal replacement research topics over time, as well as countries’ contributions.
Keywords: trachea, scientometrics, replacement, transplantation, therapeutic substitution, regeneration, trends
Introduction
Tracheal stenosis is caused by many different eti-ologies. Postintubation tracheal stenosis (the most
common cause), congenital strictures, tracheomalacia, as
well as direct tracheal traumas are very much challenging in
the field of thoracic surgery.1 Most of these lesions are
treatable with conventional methods of surgery, that is, re-
section and anastomosis. Bronchoscopic dilatation, core out
of granulation tissues, and laser therapy are also among the
methods that can be employed in some cases.2
The idea of using tracheal substitutes was raised by
Belsey’s opinion, which in turn was based on the impossi-
bility of tracheal resection more than 2 cm.3 However,
studies conducted from 1950 to 1970 showed that this
limitation could be tackled.4 At the moment, considering the
experimental progress in the field of tracheal surgery, it is
feasible to resect one half of the tracheal lesion in adults and
one third in children, and make a safe anastomosis. For the
lengthier lesions, tracheal substitutes will be required. Other
factors such as age, regional anatomy, pathology, and pre-
vious treatments also affect this limitation.5 Therefore,
many studies have been conducted to provide proper tra-
cheal substitutes with very limited success. In this regard,
the aim of these studies varies over time. Herein is a review
of these dynamic attempts.
Stents and prostheses
Different types of prostheses made of materials such as
stainless steel, silicon (Montgomery T-tube, Dumon, Rush,
Orlowski), Teflon, Vitallium, glass, polyethylene, Avalon,
and poly (vinyl alcohol) have been tested on animals and
human beings in some cases. However, the most popular are
1Tracheal Diseases Research Center (TDRC), National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid
Beheshti University of Medical Sciences, Tehran, Iran.
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the silicone and metal-based stents.6 The main limiting factor
in this group is poor biocompatibility. To improve the stents’
performance with regard to the host response, different ap-
proaches have been developed, including the fabrication of
hybrid stents,6 adding biological or biocompatible materials
such as collagen7 and Dacron,8 and employing materials with
functionalized anti-inflammatory agents.9
Moreover, to form a patient’s own tissue around the
prostheses, some investigators have made porous materials
to promote penetration of blood vessels into the prosthesis
and prevent its migration.10,11 Thus, mesh form of some
materials such as collagen, Marlex, tantalum, Dacron, sili-
cone, polytetrafluorethylene, and polypropylene has been
widely used in clinical and experimental studies.10,12
Despite the general belief that ‘‘there have been no recent
striking advances in airway stent technology’’,6 the pros-
theses designing is still advancing to make a structure with
the size of a patient’s own trachea. In this regard, Choi et al.
fabricated a bilayered porous prosthesis based on polyure-
thane (PU) and polyethylene glycol. The prostheses were
implanted in three beagles. Three-month follow-up showed
the respiratory mucosa over the prosthesis and granulation
tissue through the pores.13 In another experiment, treatment
of the tracheal defect using porous prosthesis fabricated by
Pluronic F127/PU or Pluronic F127/PCL was promising
because of the facilitation in epithelialization, but mechan-
ical insufficiency still remained an issue.14,15
Recently, a hybrid prosthesis has been created from poly
(dimethyl siloxane) and collagen, which has biomechanical
properties similar to the human trachea.16 Successful
semicircular implantations of the new prostheses made of
poly lactic acid and poly glycolic acid copolymer in dogs
have also been reported lately.17 In general, bacterial in-
fections, obstruction, granulation and lack of epithelial
coverage, and poor mechanical properties are some of the
complications related to the prosthesis.6,12 Thus, the in-
crease in biomechanical properties and biocompatibility are
constructive developments for studies aiming at fabrication
of a tracheal prosthesis.
Nonviable tissues
Researchers have employed freeze-drying, chemical fix-
ation, and freezing to eliminate or decrease the antigenicity
of connective tissues, aorta, trachea, and other tissues.
However, loss of the mechanical properties and therefore
the need for permanent stenting made them poor substi-
tutes.12 For example, in 2010, Agathos et al. treated a xe-
nograft trachea by incubating it in a glutaraldehyde solution
for 3 months and then implanted it in a pig model. However,
occlusion at the distal part of anastomosis to the native
trachea due to granulation tissue formation, made this
method inappropriate.18 Altogether, there is no adequate
number of studies focused on replacing the trachea with
these types of materials, and after introducing tissue engi-
neering, they were more used as biological scaffolds rather
than tracheal substitutes.
Autogenous tissues
Pericardium, omentum, fascia, skin, pleura, and synovial
membrane12 with the support of solid prostheses are con-
sidered substitutes for the trachea in many studies. Despite
the reepithelialization and low risk of necrosis as advan-
tages, some disadvantages like the surgical risk of harvest-
ing the autogenous tissues and necessity of stenting make
autogenous grafts suitable only to deal with special cases.19
Recently, replacing trachea by using a patient’s bronchial
walls and lung tissue has had good results as well.20
Autogenous tissues in composite graft. Considering the
restrictions caused by stenting in autogenous tissues, other
therapeutic options are applied by fabricating composite
grafts.12 Indeed, the patient’s own rib or cartilage is employed
to prepare rigidity of the graft, and coverage of the respiratory
epithelium is provided by using skin or buccalmucosa. In 2009
Fujiwara et al. used rib’s cartilages and free flap fascia of the
forearm to create a composite by two-stage prefabricated ra-
dial forearm free flap tracheal reconstruction. However, due to
the procedure risks and the time-consuming process, this
method has not been popularized over the time.21
Tracheal transplantation
The first successful tracheal transection and reanastomosis
belong to Gluck in 1881.22 Almost 40 years later, through
removing three to nine tracheal rings and regrafting in canine
model, Burket showed that a long-segment autograft is im-
practicable.12 Other complementary studies in 1950 s noted
the pivotal role of blood supply in tracheal transplantation.23
Thereupon, further studies continued based on preparing
blood flow through direct or indirect vascularization, in one
or two stages.24
Tracheal allotransplantation. The first allograft transplant
in 1954 failed due to ischemia and high antigenic properties of
the epithelial cells.12 In 1979, Rose and Sesterhenn performed
a study based on the allotransplantation on rat model. After
280 days, the results indicated that tracheal tissues possess
only minor organ-specific antigenicity.25 These findings led to
the first allograft transplantation taken from a brain-dead donor
and prevascularized in the sternocleidomastoid muscle, with-
out application of any immunosuppressant drugs.26 The lack of
further reports of the patient’s condition may be due to graft
rejection. In this regard, in 1984, Beigel and his colleagues
conducted a series of studies on inbred rats and demonstrated
the antigenicity of the tracheal epithelium.27 Therefore, they
offered a strong evidence-based option to the controversy of
tracheal antigenicity in the existing literature. Afterward,
prescription of immunosuppressive drugs has been suggested
in tracheal transplantations.28
Transplantation of the cryopreserved trachea. The first
report of a cryopreserved tracheal transplantation was
published in 1951.29 This method reduced the tracheal an-
tigenicity of chondrocytes and epithelium. It is worth men-
tioning that a long period of cryopreservation is required to
decrease antigenicity, which may lead to low cell viability.
Therefore, the efficacy of this method depends on the period
of cryopreservation. In 2000, seven patients underwent tra-
cheal transplantation using cryopreserved trachea. Three
patients were decannulated within 20 months of follow-
up. Based on these findings, researchers concluded that the
cryopreserved trachea could be a valuable alternative for
tracheal reconstruction.30
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Some experimental studies also confirmed the effect of
freeze/thaw cycles on decreasing the antigenicity, but the
remaining cell surface antigens would lead to chronic re-
jection.31 Further researches are required to evaluate the
mechanism of synergistic effects of both cryopreservation
and adequate immunosuppression.
Autograft–allograft composite grafts. In 2010, Delaere,
who had criticized misconducting scientists for considering
trachea as a well-suited organ for tissue engineering previ-
ously,32 reconstructed a long-segmented tracheal defect
using a vascularized composite graft made of recipient
buccal mucosa and tracheal allograft. In this research, im-
munosuppressive therapy was administered during hetero-
topic transplantation, while the graft was wrapped in the
recipient’s forearm fascia for vascularization.28
Aorta as a tracheal graft
Tracheal replacement with processed aortic graft has been
taken into account as a bioprosthesis from 1959.12 Martinod
et al. began to replace the trachea with a carotid artery in
1997 and then continued their work with different lengths of
the aorta in sheep animal models.33 What is noteworthy in
this method is the transformation of intima layer of the aorta
into the cartilage tissue.34 The proposed theories include
chondrocyte transformation of primary intimal cells and
differentiation of arrived stem cells from circulation in the
aorta wall because of the local ischemia.35
Since the chondrocytes that appeared in the lining of the
aorta did not develop enough rigidity in aorta tissue, stenting
was required to prevent the collapse of the aortic walls.
Based on the results obtained from aorta transplantation, six
patients underwent tracheal transplantation in 2005 using
two fresh aortas and four cryopreserved ones. A flap from
pectoralis muscle was taken to support perfusion and no
immunosuppressive drugs were administered. Calcification,
graft contraction, infections, spinal cord ischemia, and
esophageal fistula were reported in the follow-up.36 In an-
other experiment, Jacques et al. employed a long segment of
the autologous aorta to reconstruct tracheal stenosis in a 68-
year-old patient.37 Overall, the results obtained from clini-
cally used aorta graft confirmed the possibility of replacing
both the main stem bronchus and long segment of the tra-
chea with aorta graft, in urgent conditions. Furthermore, the
results of (TRACHEO- BRONC-ART study) would provide
the required data for this implantation approach.38
Bioengineering of the trachea
The emergence of tissue engineering in 1993 opened up a
new horizon in the field of tissue regeneration. Indeed, the
simple structure of the trachea made it suitable as the first
tissue-engineered organ.39 The first research to employ this
method was performed in 1994 and was conducted by fab-
ricating a synthetic scaffold made of poly glycolic acid and
transplanting it in mice.40 Soon, the findings obtained from
relevant studies indicated that the mechanical properties and
vascularization are the main criteria for proper substitutes.
Subsequently, many other types of research were conducted
to provide blood supply and improve the biomechanics of
the constructs.
Synthetic and biological scaffolds. Scaffolds, which are
templates similar to extracellular matrix (ECM), are used to
guide the growth of new tissues. The structures of scaffolds
are usually porous and basically synthetic or biological in
nature. A scaffold should be biocompatible and biodegrad-
able to be suitable for tissue engineering.41 The degradation
rate should be coordinated with the speed of natural tissue
formation to maintain the physiological function of the tis-
sue.42 Alginate, collagen, hyaluronic acid, fibrin, and chit-
osan can be mentioned as natural materials and poly (lactic
acid), poly (glycolic acid), and poly (caprolactone) are ex-
amples of synthetic polymers. Various methods have been
proposed to produce scaffolds with proper porosity in size
and connections. These methods include casting, phase
separation, melt molding, freeze-drying, and electrosp-
inning. Biological scaffolds are usually made of ECM by
removing cellular components and have found many ap-
plications in reconstructive surgery. ECM is secreted by
tissue cells and is in a dynamic equilibrium with them.43
Decellularization procedures affect the texture, surface
structure, and composition of tissue in addition to reducing
cellular antigens. Consequently, various methods and ma-
terials are applied for decellularization to diminish negative
effects on mechanical properties.
Recently, coculture strategies have been aimed to combine
differentiated primary cells with the proliferative potential of
MSCs to solve the above-mentioned limitations.44 Subse-
quently, the coculture of cells resulted in synergistic specific
tissue formation in both the plate surface area and 3D envi-
ronments. As a whole, a suitable tracheal substitute should be
(1) rigid laterally, (2) flexible longitudinally, (3) covered with
ciliated epithelium of the respiratory tract, (4) airtight, (5)
compatible with trachea to avoid chronic inflammation,
granulation tissue formation, infection, and erosion, (6)
nontoxic, (7) nonimmunogenic, (8) noncarcinogenic, and (9)
vascularized. Taken together, the aim of this study is to
evaluate the tracheal replacement field using co-occurrence
analysis45 to identify the most important issues and provide
an assessment of the trends over time. Iran’s productions and
their international relationships were also analyzed.
Methods
Data sources
PubMed and Scopus were used to cover articles related to
tracheal replacement, as many as possible. We also used
Web of Science (WOS) to cover various fields such as
keywords, countries, organizations, and authors that were
important for literature analysis and scientometry.
Strategy of search
Given the role of keywords in the evaluation of research
trends in any field of science, this study used only Medical
Subject Headings (MeSH) keywords to achieve more accurate
results. Scientific articles indexed in the above-mentioned
databases were retrieved by the end of December 2015. For
example, the query used for WOS database was as follows:
TS= [(Trachea* OR ‘‘air way’’ OR bronchi) AND (Bioengi-
neering OR ‘‘Bio-Engineering’’ OR ‘‘Biological Engineer-
ing’’ OR Reconstruction OR Regeneration OR Regenerative
OR Replacement OR Transplantation OR Transplants)].
120 GHORBANI ET AL.
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Methodologies
Co-occurrence analysis was applied to evaluate the publica-
tions among bibliometric indexes.46 Bibexcel was employed to
prepare and clean the data, determine co-occurrencematrix, and
organize network output files. VOSviewer 1.6.1 was used for
scientific mapping and clustering the themes. NetDraw 2.153
was used to delineate indicators of social network analysis.
Mapping
To prepare authors’ network, search results of WOS were
entered into VOS viewer software and the 60 most pro-
ductive authors and their relationships were identified. In
addition, countries contributing to the production of articles
were retrieved as well and those ranking among the first 25
were determined.
Density Drawing was prepared to visualize the trend of
this particular field of research. For keyword analysis, the 10
co-occurred words with highest frequency were examined
by 5-year intervals (from 1995 to 2015) and before 1995. In
terms of hot topics and common keywords used in the title
of articles in PubMed, Scopus, and WOS databases, the 100
co-occurred words were assessed and then visualized by
VOSviewer 1.6.1.
Results
Therewere 3438, 1751, and 3009 total tracheal replacement-
related articles in the WOS, Scopus, and PubMed databases,
respectively. The first 15 words of each database are com-
pared in Table 1. Figure 1 also shows network visualization
of the results.
In sum, a total of 65 countries have contributed to the
production of articles in this field. USA, Japan, Germany,
United Kingdom, and France have the largest share of
publications in this field. Iran has 24 articles and is ranked
23th among the 65 countries in the list (Fig. 2).
Among 12,178 authors, as it is depicted in Figure 3, the
five top authors were NakamuraT, Patterson G, Grillo H,
Kim J, and Macchiarini P. In this network map, nodes are
represented as writers and ties are represented as coopera-
tion. The diameter of the circle indicates the abundance of
articles, and the thickness of the lines indicates the scientific
collaboration of authors. Given the structure of the network,
most articles and the largest number of collaborations were
related to a Japanese scientist—Nakamura. Furthermore, the
most cooperation was among Nakamura– Shimizu with 20
articles and Jungebluth–Macchiarini with 16 articles.
Publication trends before 1995
Considering the 10 co-occurrence threshold, 51 out of the
732 keywords in this period met the predetermined condi-
tions (Fig. 4A). The words ‘‘lung transplantation,’’
‘‘bronchiolitis obliterance,’’ and ‘‘tracheal stenosis’’ had the
highest frequency and words such as ‘‘stent,’’ ‘‘prosthesis,’’
‘‘animal study,’’ and ‘‘tissue engineering’’ did not appear on
the map.
Fourteen clusters have been obtained and the term
‘‘bronchoplasty’’ has been proposed among methods for
tracheal reconstruction and was in the hot region, but the term
‘‘tracheoplasty’’ was in the cold zone. ‘‘Bronchi,’’ ‘‘lung
transplantation,’’ ‘‘laryngotracheal reconstruction,’’ ‘‘injury &
denervation,’’ ‘‘bronchoscopy,’’ ‘‘cAMP,’’ ‘‘bronchiolitis
obliterance,’’ ‘‘tracheoplasty,’’ and ‘‘trachea’’ were the first
terms in some of the clusters.
Publication trends during 1996–2000 period
In this period, among 478 items, 34 keywords met the
threshold and 9 clusters were categorized (Fig. 4B).
The words ‘‘lung transplantation,’’ ‘‘tracheal stenosis’’
and ‘‘stent,’’ ‘‘infant,’’ ‘‘child,’’ and ‘‘tracheostomy’’ had
high frequency and were in the hotspot area. The terms
‘‘immunosuppression,’’ ‘‘tracheoplasty,’’ and ‘‘bronchos-
copy’’ appeared in the cold region. Words such as ‘‘animal
study’’ and ‘‘tissue engineering’’ did not even appear on the
map. ‘‘Transplant’’ has been generally mentioned, but the
exact words ‘‘allograft and autograft transplantations’’ were
not observed on the map. The term ‘‘respiratory distress
syndrome,’’ which was a common phrase before 1996, was
located in the cold region in this period. Nine clusters have
been obtained that are summarized in Table 2.
Publication trends during 2001–2005 period
There were 77 items out of 477 that met the criteria and
13 clusters were identified. The keywords ‘‘cartilage,’’
‘‘tissue engineering,’’ ‘‘Allograft,’’ ‘‘chronic rejection,’’
and ‘‘balloon dilatation’’ emerged among the hotspots on
the map (Fig. 4C). The word ‘‘rat’’ in this period appeared
in the cold zone. Among the keywords related to ‘‘carti-
lage,’’ the terms ‘‘tissue engineering,’’ ‘‘congenital anom-
aly,’’ ‘‘tracheal malformation,’’ and ‘‘fetal surgery’’ were
similar to it. Moreover, items like ‘‘scaffold’’ or ‘‘prefab-
rication’’ have not met the threshold of 10 co-occurrences.
Publication trends during 2006–2010 period
In this interval, 76 items out of 754 keywords met the 10
co-occurrence threshold. Among animal models ‘‘rat’’ and
Table 1. Common Words Used as a Keyword
in Different Databases
WOS PubMed Scopus
Cartilage Animal Human
Graft Human Tracheal stenosis
Tissue
engineering
Adult Bronchoscopy
Resection Dog Case report
Stent Homologous
transplantation
Infant
Allograft Rats Lung transplantation
Blood supply Mice Controlled study
Tracheostomy Bronchoscopy Neoplasm
Stem cell Treatment Tracheal
reconstruction
Rat Follow-up studies Postoperative
complications
Autologous Cell culture Anastomosis surgery
Laser Rabbit Retrospective studies
Scaffold Tissue
engineering
Animal experiment
Biocompatible Stent Stent
Subglottic Graft rejection Rat
WOS, Web of Science.
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‘‘rabbit’’ caught the attention and ‘‘rat’’ in particular ap-
peared in the hot zone and in the region related to ‘‘lung
transplant’’ and ‘‘bronchiolitis oblitrans.’’ Figure 4D shows
the trends of keywords used from 2006 to 2010. The words
‘‘fibroblast,’’ ‘‘epithelial stem cell(s),’’ ‘‘mesenchymal stem
cell(s),’’ ‘‘scaffold,’’ ‘‘cartilage,’’ ‘‘polypropylene,’’ ‘‘me-
chanical properties,’’ and ‘‘ECM’’ could be observed in the
field of ‘‘tissue engineering’’. Keywords including ‘‘pre-
fabrication,’’ ‘‘sleeve resection,’’ and ‘‘lung neoplasm’’
emerged in the map, although placed in the cold area.
Publication trends during 2011–2015 period
‘‘Bioengineering’’ and ‘‘tissue engineering’’ are still
among the hotspots in 2011–2015 (Fig. 5). There was a
noted attention to ‘‘collagen’’ in this period. The keyword
‘‘Mice’’ has been more commonly used in experimental
studies. Words ‘‘angiogenesis’’ and ‘‘decellularization’’
appeared in hotspots in this period in ‘‘tissue engineering’’
cluster. In this interval, ‘‘Cross-linking agents,’’ ‘‘extracel-
lular matrix,’’ and ‘‘mechanical properties’’ were also con-
sidered. Despite being present on the map, the terms
‘‘immunosuppression,’’ ‘‘bioreactor,’’ and ‘‘trachea trans-
plantation’’ were in the cold zones.
Discussion
In this study, topics and trends of tracheal replacement
research field were assessed, using co-occurrence analysis.
Scientific maps indicated that studies are dynamically
FIG. 1. Common keywords
according to 100
co-occurrence. (A) PubMed-
indexed articles; (B) Scopus-
indexed articles. Color images
available online at www
.liebertpub.com/teb
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expanded over time and among different periods; various
strategies have been employed to overcome the limitations
of each alternative.
As Grillo has mentioned in his critical review, ‘‘unlike
other transplantation, alternative air passages are rarely
lifesaving and are basically for improving the patient’s
condition’’.12 Therefore, all the criteria of a suitable alter-
native should be met. Before 1995, the terms prosthesis and
stent were not prominent in the literature. In this period,
lung transplantation and its complications such as bronch-
iolitis obliterans were subjects of most studies.
In the second interval, the word stent was a common word
and tracheal reconstruction along with cricotracheal resec-
tion appeared in the same cluster. Tracheal reconstruction
was more significant than replacement. Tissue engineering
was not in the relevant drawing yet, although in the last two
decades, tissue engineering has opened new horizons in this
field. In 1994, the first studies on tracheal bioengineering in
an animal model aspired scientists that access to a suitable
alternative may be at hand.40 The term cartilage emerged in
2001 because of its important role in tracheal rigidity as-
surance. Many preconceived ideas like foreign material,
bioprosthesis, aorta, autogenous tissue, and allograft re-
placements were combined with tissue engineering and
numerous studies were conducted to investigate this topic.
The first artificial tracheal transplantation was implemented
FIG. 3. Cooperation of the first 130 authors. Color images available online at www.liebertpub.com/teb
FIG. 2. Twenty-five top coun-
tries contributed in producing arti-
cles. Color images available online
at www.liebertpub.com/teb
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in a 58-year-old patient in 2003.47 The bioartificial construct
was prepared from acellular porcine jejunum as collagen
matrix. Collagen as a natural biomaterial was a common
subject since 2006. Gradually, ECM, which is derived from
decellularized trachea, was applied in many experimental
researches. Later on, tracheal replacement through autolo-
gous cell-seeded biological scaffold turned out to be a
lifesaving option for another patient who suffered from
tracheal agenesis, following various unsuccessful alternative
treatment methods, including stenting and allograft trans-
plantation. However, progressive stenosis in the proximal
portion of the graft caused permanent stenting.48
After a while, the terms scaffold, polypropylene, and
biomechanic were taken into consideration, resulting in a
cascade of studies that aimed to improve the mechanical
properties of acellular scaffolds, and therefore ‘‘decellular-
ization’’ became a common keyword during the past 5
years. Finally, the weak points of biological scaffolds, in-
cluding (1) the time-consuming procedure, (2) the biome-
chanical inadequacy, (3) the possibility of infection, (4) the
size match limitation, and (5) the donor shortage,50,51 have
led scientists to believe that ‘‘synthetic biomaterials may
ultimately provide a more reliable model for simple struc-
tures such as trachea’’.49 Thus, the investigators have con-
centrated on the fabrication and optimization of synthetic
scaffolds in the clinic. The first tracheal replacement using
tailored bioartificial nanocomposite scaffold was performed
in 2011.50 The autologous, cell-seeded, Y-shape nonde-
gradable scaffold was rigid enough to prevent collapse;
however, granular tissue appeared in the left bronchus and
complementary studies are ongoing to address the material
biocompatibility.
As a whole, these findings depicted the status and trends
of different approaches applied to develop an off the shelf
tracheal alternative. Therefore, the researchers and policy
makers could forecast the dynamic directions of these re-
searches and take actions to support them. Possibly, the best
approach is to combine these ideas together to create a
hybrid structure, including the strong points of both syn-
thetic and biological scaffolds.51
FIG. 4. The trends of keywords used in different intervals, according to 10 co-occurrence. (A) Before 1995; (B) from
1996 to 2000; (C) from 2001 to 2005; (D) from 2006 to 2010. Color images available online at www.liebertpub.com/teb
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FIG. 5. (A) Keywords used from 2011 to 2015 according
to 10 co-occurrence; (B) keywords related to tissue engi-
neering, found at the second layer of the map; (C) the third
layer of tissue engineering hot zone and related keywords.
Color images available online at www.liebertpub.com/teb
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